NASDAQ:NGNE | Free Cash Flow | Neurogene Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2012-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$26.12M$281,000.00-$26.4M
2025-12-31-$17.43M$128,000.00-$17.56M
2025-03-31-$20.77M$780,000.00-$21.55M
2024-12-31-$17.5M$116,000.00-$17.61M
2024-03-31-$21.65M$65,000.00-$21.72M
2023-12-31-$16.97M$128,000.00-$17.1M-717.58%
2023-03-31-$13.56M$29,000.00-$13.58M
2022-12-31-$18.15M$1.22M-$19.37M
2022-03-31-$14.09M$452,000.00-$14.54M
2021-12-31-$12.17M$396,000.00-$12.56M
2021-03-31-$13.36M$1.09M-$14.45M
2020-12-31-$9.23M$653,000.00-$9.88M
2020-03-31-$6.44M$107,000.00-$6.55M
2019-12-31-$4.64M$782,000.00-$5.42M
2019-03-31-$2.76M
2018-12-31-$9.78M$0.00-$9.78M
2018-03-31-$15.59M$40,000.00-$15.63M
2017-12-31-$11.61M$16,000.00-$11.62M
2017-03-31-$11.28M$108,000.00-$11.39M
2016-12-31-$9M$97,000.00-$9.09M
2016-03-31-$5.87M$27,000.00-$5.9M
2015-12-31-$3.96M$10,000.00-$3.97M
2015-03-31-$6.3M$6,000.00-$6.31M
2014-12-31-$6.69M$28,000.00-$6.72M
2014-06-30-$2.81M$64,611.00-$2.87M
2014-03-31-$3.8M$4,000.00-$3.81M
2013-12-31-$3.74M$3,767.00-$3.74M
2013-06-30-$1.44M$2,537.00-$1.44M
2013-03-31-$896,621.00$4,696.00-$901,317.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$77.17M$1.18M-$78.36M
2024-12-31-$70.6M$808,000.00-$71.41M
2023-12-31-$51.42M$321,000.00-$51.74M
2022-12-31-$52.82M$2.23M-$55.05M
2021-12-31-$47.56M$3.26M-$50.82M
2020-12-31-$24.58M$2.22M-$26.79M
2019-12-31-$15.39M$879,000.00-$16.27M
2018-12-31-$31.58M$49,000.00-$31.63M
2017-12-31-$44.72M$494,000.00-$45.21M
2016-12-31-$30.23M$713,000.00-$30.94M
2015-12-31-$20.27M$26,000.00-$20.29M
2014-12-31-$17.49M$114,000.00-$17.6M
2013-12-31-$7.82M$11,000.00-$7.83M
2012-12-31-$7.23M$6,447.00-$7.24M